These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33336359)

  • 1. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
    Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD
    J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
    Brigo F; Bragazzi N; Nardone R; Trinka E
    Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
    Misra UK; Kalita J
    Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Lamb N; Loddenkemper T
    Neurology; 2019 May; 92(20):e2339-e2348. PubMed ID: 31068480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.
    Sathe AG; Elm JJ; Cloyd JC; Chamberlain JM; Silbergleit R; Kapur J; Cock HR; Fountain NB; Shinnar S; Lowenstein DH; Conwit RA; Bleck TP; Coles LD
    Epilepsia; 2020 Jun; 61(6):e66-e70. PubMed ID: 32420641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
    Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
    Naeem B; Ashfaq M; Qureshi MA
    J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus.
    Hovinga CA; Chicella MF; Rose DF; Eades SK; Dalton JT; Phelps SJ
    Ann Pharmacother; 1999 May; 33(5):579-84. PubMed ID: 10369622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of intravenous levetiracetam in status epilepticus: A meta-analysis and systematic review.
    Chu SS; Wang HJ; Zhu LN; Xu D; Wang XP; Liu L
    Seizure; 2020 Jan; 74():49-55. PubMed ID: 31830677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
    Coralic Z; Kapur J; Olson KR; Chamberlain JM; Overbeek D; Silbergleit R
    Ann Emerg Med; 2022 Sep; 80(3):194-202. PubMed ID: 35718575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis.
    Brigo F; Del Giovane C; Nardone R; Trinka E; Lattanzi S
    Epilepsy Behav; 2019 Dec; 101(Pt B):106466. PubMed ID: 31462385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Effectiveness of Levetiracetam Compared to Fosphenytoin in the Treatment of Benzodiazepine Refractory Convulsive Status Epilepticus.
    Nalisetty S; Kandasamy S; Sridharan B; Vijayakumar V; Sangaralingam T; Krishnamoorthi N
    Indian J Pediatr; 2020 Jul; 87(7):512-519. PubMed ID: 32088913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus.
    Coles LD; Leppik IE; Patterson EE; Rivers Z; Mishra U; Cloyd JC
    Epilepsia; 2015 Jun; 56(6):888-94. PubMed ID: 25952988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from the Established Status Epilepticus Treatment Trial.
    Cock HR; Coles LD; Elm J; Silbergleit R; Chamberlain JM; Cloyd JC; Fountain N; Shinnar S; Lowenstein D; Conwit R; Bleck TP; Kapur J
    Epilepsy Behav; 2019 Dec; 101(Pt B):106296. PubMed ID: 31653603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.